PROJECTS & FUNDING
All currently running academic research projects and individual grants will be mentioned here, along with short summaries and key personnel involved.
Research Projects
Personal Grants
Optimizing NM delivery to solid tumors by pharmaceutical and physical means
FWO-SB - ends 31/12/2022
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshian
Mukaddes Izci
A multidisciplinary approach for the treat-ment of immune-suppressed ovarian cancer
KU Leuven C2 - ends 30/09/2022
People involved:
Prof. Stefaan Soenen
Bart Coenaerts
Ann Vankerckhoven
Development and validation of optical imaging tools for advanced preclinical cancer research
FWO-SB - ends 31/12/2022
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshia
Evelien Hesemans
A multidisciplinary study on the use of biodegradable nanocarriers for the specific delivery of pharmaceutics in lungs of premature babies
KU Leuven C2 - ends 30/09/2022
People involved:
Dr. Bella Manshian
Prof. Jaan Toelen
Yannick Regin
Vincent Lenders
A multidisciplinary study on the use of biodegradable nanocarriers for the specific delivery of pharmaceutics in lungs of premature babies
FWO-SB - ends 31/12/2022
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshia
Yannick Regin
Evaluation of nanomaterial-mediated induction of immunogenic cell death as novel anticancer therapy
FWO Research Grant - ends 31/12/2022
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshian
Christy Maksoudian
A complementary in vivo-in silico approach to optimize nanomaterial delivery to solid tumors
BOF CELSA fund - ends 31/10/2022
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshian
Mukaddes Izci
Kiana Buttiens
Valorization and translation of preclinical nanomedicine research findings
Wellcome Trust iTPA
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshian
Implementation of preclinical optical imaging and nano-immunotherapy as anti-cancer research tools
FIKO - ends 31/10/2022
People involved:
Prof. Stefaan Soenen
Ultrasensitive multiplexed optical imaging methods: the true meaning of shedding light in the dark
BOF funding C3 - ends 31/01/2024
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshian
Nanoparticle-mediated immunotherapy for improved cancer treatment
BOF funding C3 - ends 30/09/2024
People involved:
Prof. Stefaan Soenen
Dr. Bella Manshian